Fleenor; Debra L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fleenor; Debra L..The latest application filed is for "control of intraocular pressure using alk5 modulation agents".

Company Profile

0.2.25

Fleenor; Debra L. - Crowley TX
Fleenor, Debra L - Benbrook TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Control Of Intraocular Pressure Using Alk5 Modulation Agents App 20120115870 - Fleenor; Debra L. ; et al.	2012-05-10
Prenyltransferase Inhibitors For Ocular Hypertension Control And The Treatment Of Glaucoma App 20120108632 - Shepard; Allan R. ; et al.	2012-05-03
Use Of Inhibitors Of Jun N-terminal Kinases To Treat Glaucoma App 20120004274 - Fleenor; Debra L. ; et al.	2012-01-05
Control Of Intraocular Pressure Using Alk5 Modulation Agents App 20110160210 - Fleenor; Debra L. ; et al.	2011-06-30
Pai-1 Expression And Activity Inhibitors For The Treatment Of Ocular Disorders App 20110105574 - Fleenor; Debra L. ; et al.	2011-05-05
Statins For The Treatment Of Ocular Hypertension And Glaucoma App 20110098314 - Hellberg; Mark R. ; et al.	2011-04-28
Agents Which Regulate, Inhibit, Or Modulate The Activity And/or Expression Of Connective Tissue Growth Factor (ctgf) As A Unique Means To Both Lower Intraocular Pressure And Treat Glaucomatous Retinopathies/optic Neuropathies App 20110092523 - Fleenor; Debra L. ; et al.	2011-04-21
Use Of Inhibitors Of Jun N-terminal Kinases To Treat Glaucoma App 20100311716 - Fleenor; Debra L. ; et al.	2010-12-09
Pai-1 Binding Modulators For The Treatment Of Ocular Disorders App 20100260784 - Fleenor; Debra L. ; et al.	2010-10-14
Antagonists Of Ci-m6p/igf2r For Prevention And Treatment Of Ctgf-mediated Ocular Disorders App 20100247548 - Shepard; Allan R. ; et al.	2010-09-30
Use of inhibitors of Jun N-terminal kinases to treat glaucoma Grant 7,803,824 - Fleenor , et al. September 28, 2	2010-09-28
Antagonists Of Endothelial Differentiation Gene Subfamily 3 (edg-3, S1p3) Receptors For Prevention And Treatment Of Ocular Disorders App 20100183629 - Fleenor; Debra L. ; et al.	2010-07-22
Pai-1 Modulators For The Treatment Of Ocular Disorders App 20100158897 - Fleenor; Debra L. ; et al.	2010-06-24
Prenyltransferase Inhibitors For Ocular Hypertension Control And The Treatment Of Glaucoma App 20100120851 - SHEPARD; Allan R. ; et al.	2010-05-13
Pai-1 Expression And Activity Inhibitors For The Treatment Of Ocular Disorders App 20090202524 - Fleenor; Debra L. ; et al.	2009-08-13
Agents Which Regulate, Inhibit, Or Modulate The Activity And/or Expression Of Connective Tissue Growth Factor (ctgf) As A Unique Means To Both Lower Intraocular Pressure And Treat Glaucomatous Retinopathies/optic Neuropathies App 20080176964 - Fleenor; Debra L. ; et al.	2008-07-24
Inhibitors Of Protein Kinase C-delta For The Treatment Of Glaucoma App 20080153903 - FLEENOR; Debra L. ; et al.	2008-06-26
Pai-1 Binding Modulators For The Treatment Of Ocular Disorders App 20080107644 - FLEENOR; Debra L. ; et al.	2008-05-08
Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies Grant 7,351,407 - Fleenor , et al. April 1, 2	2008-04-01
Antagonists Of Ci-m6p/igf2r For Prevention And Treatment Of Ctgf-mediated Ocular Disorders App 20080057072 - SHEPARD; Allan R. ; et al.	2008-03-06
Antagonists Of Endothelial Differentiation Gene Subfamily 3 (edg-3, S1p3) Receptors For Prevention And Treatment Of Ocular Disorders App 20080025973 - FLEENOR; Debra L. ; et al.	2008-01-31
Prenyltransferase Inhibitors For Ocular Hypertension Control And The Treatment Of Glaucoma App 20070232675 - Shepard; Allan R. ; et al.	2007-10-04
Control Of Intraocular Pressure Using Alk5 Modulation Agents App 20070142376 - FLEENOR; Debra L. ; et al.	2007-06-21
Use of inhibitors of Jun N-terminal kinases to treat glaucoma App 20060172991 - Fleenor; Debra L. ; et al.	2006-08-03
Statins for the treatment of ocular hypertension and glaucoma App 20050239871 - Hellberg, Mark R. ; et al.	2005-10-27
Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies App 20050234075 - Fleenor, Debra L. ; et al.	2005-10-20
Use of propentofylline to control intraocular pressure App 20040110776 - Pang, Iok-hou ; et al.	2004-06-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.